Reports- Sanger Sequencing Service Market | Page 3

1.2.2 Type 2
1.3 Market Analysis by Applications
1.3.1 Bioscience Companies
1.3.2 Hospitals
1.3.3 Institutions
1.4 Market Analysis by States
1.4.1 California Status and Prospect (2012-2022)
1.4.2 Texas Status and Prospect (2012-2022)
1.4.3 New York Status and Prospect (2012-2022)
1.4.4 Florida Status and Prospect (2012-2022)
1.4.5 Illinois Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Source BioScience
2.1.1 Profile
2.1.2 Sanger Sequencing Service Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Source BioScience Sanger Sequencing Service Sales, Price, Revenue, Gross Margin and
Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Source BioScience News
2.2 GenScript
2.2.1 Profile
2.2.2 Sanger Sequencing Service Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 GenScript Sanger Sequencing Service Sales, Price, Revenue, Gross Margin and Market Share
(2016-2017)
2.2.4 Business Overview
2.2.5 GenScript News
2.3 Thermofisher
2.3.1 Profile
2.3.2 Sanger Sequencing Service Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Thermofisher Sanger Sequencing Service Sales, Price, Revenue, Gross Margin and Market
Share (2016-2017)
2.3.4 Business Overview
2.3.5 Thermofisher News
2.4 Nucleics
2.4.1 Profile
2.4.2 Sanger Sequencing Service Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Nucleics Sanger Sequencing Service Sales, Price, Revenue, Gross Margin and Market Share
(2016-2017)